![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/11/GS-6207-is-a-First-In-Class-HIV-1-Capsid-Inhibitor-with-Long-Acting-Potential-2019-12-04.jpg)
Exceptional developments in combination antiretroviral therapy (cART) have transformed HIV/AIDS from a deadly pandemic to chronic and manageable disease. HIV-1…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/05/GSK3532795-HIV1-Maturation-Inhibitor-GSK3532795-2019-05-18-1.jpg)
Human immunodeficiency virus (HIV) is a threat to humans and a serious issue for public health worldwide. Especially, acquired immune…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/05/MLT-748-Allosteric-MALT1-Inhibitor-Molecular-Corrector-Rescue-Function-in-Immunedeficiency-2019-05-12.jpg)
In previous blog “MLT-747, an Allosteric MALT1 Inhibitor for Immunodeficiency Research”, we introduced MLT-747 as a potent, selective, allosteric inhibitor…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/05/MLT-747-Allosteric-MALT1-Inhibitor-for-Immunodeficiency-Research-2019-05-11.jpg)
Immunodeficiency is a state, in which the immune system’s ability is absent. It is not able to fight against cancer…